Biotech · Private company · New Haven, CT, US
Panluminate Inc.
Track this companyFree. Adds Panluminate Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Development of pan-ExM for whole-brain, molecularly annotated connectomicsFiscal year 2026 · $454.6KNIH RePORTER 1R43MH143449-01 · fetched Nov 12, 2026
- AI-Enabled Expansion Microscopy Platform for Renal PathologyFiscal year 2026 · $355KNIH RePORTER 1R44DK148299-01 · fetched Nov 12, 2026
- pan-XLSM: an AI-powered microscopy platform for imaging and analysis of highly expanded tissue samplesFiscal year 2026 · $1.1MNIH RePORTER 5R44GM159519-02 · fetched Nov 12, 2026
- Development of multiplexed nanoscopy for ultrastructural phenotyping of retinal tissueFiscal year 2026 · $573.4KNIH RePORTER 5U01EY037213-02 · fetched Nov 12, 2026
- FLASH-pulse: A versatile multiplexed tissue imaging solution for research on agingFiscal year 2025 · $397.9KNIH RePORTER 1R43AG092073-01 · fetched Nov 12, 2026
- Development of ChromEx30 for Nanoscale Imaging of Genetic Organization and Disease PhenotypesFiscal year 2025 · $404.1KNIH RePORTER 1R43HG014432-01 · fetched Nov 12, 2026
- High-throughput spatial proteomics in pulmonary research with FLASH multiplex imagingFiscal year 2025 · $312.1KNIH RePORTER 1R43HL180139-01 · fetched Nov 12, 2026
- pan-XLSM: an AI-powered microscopy platform for imaging and analysis of highly expanded tissue samplesFiscal year 2025 · $1.4MNIH RePORTER 1R44GM159519-01 · fetched Nov 12, 2026
- Development of multiplexed nanoscopy for ultrastructural phenotyping of retinal tissueFiscal year 2025 · $583.2KNIH RePORTER 1U01EY037213-01 · fetched Nov 12, 2026
- A 3D super-resolved platform for rapid and highly multiplexed proteomicsFiscal year 2025 · $726.2KNIH RePORTER 5R44MH128999-03 · fetched Nov 12, 2026